{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:52:12Z","timestamp":1777661532731,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bcp.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T12:59:47Z","timestamp":1467550787000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir"],"prefix":"10.1016","volume":"115","author":[{"given":"Tomas","family":"Laho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika L.","family":"Dzierlenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Goedken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Micuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.07.001_b0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/rmv.1849","article-title":"Current treatment of hepatitis B virus infections","volume":"25","author":"De Clercq","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bcp.2016.07.001_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/14656566.2012.649727","article-title":"Adefovir dipivoxil in chronic hepatitis B: history and current uses","volume":"13","author":"Segovia","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bcp.2016.07.001_b0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0091270005278949","article-title":"Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration","volume":"45","author":"Kearney","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2016.07.001_b0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2016.07.001_b0025","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2016.07.001_b0030","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/apt.12251","article-title":"Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B","volume":"37","author":"Hartono","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2016.07.001_b0035","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14740338.2011.593507","article-title":"Drug safety evaluation of adefovir in HBV infection","volume":"10","author":"Vigan\u00f2","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bcp.2016.07.001_b0040","first-page":"1","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","author":"Hardwick","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2016.07.001_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jgh.12700","article-title":"Hepatitis B virus infection and metabolic syndrome: fact or fiction?","volume":"30","author":"Wang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2016.07.001_b0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1478-3231.2007.01482.x","article-title":"Impact of non-alcoholic fatty liver disease on chronic hepatitis B","volume":"27","author":"Bondini","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2016.07.001_b0055","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ABC-transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0060","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/dmd.113.055996","article-title":"Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models","volume":"42","author":"Canet","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2009.04.002","article-title":"Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats","volume":"613","author":"Fisher","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.07.001_b0070","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","author":"Lickteig","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/dmd.114.062703","article-title":"Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis","volume":"43","author":"Canet","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0080","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.113.211284","article-title":"Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression","volume":"348","author":"Clarke","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.07.001_b0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/dmd.114.060574","article-title":"Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis","volume":"43","author":"Canet","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2006.04.047","article-title":"Tubular transporters and clearance of adefovir","volume":"540","author":"Servais","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.07.001_b0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2016.07.001_b0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","article-title":"Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans","volume":"59","author":"Maeda","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2016.07.001_b0105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2016.07.001_b0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/135965350701200211","article-title":"Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors","volume":"12","author":"Cihlar","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bcp.2016.07.001_b0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","article-title":"Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis","volume":"39","author":"George","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2016.07.001_b0120","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1128\/AAC.45.12.3462-3467.2001","article-title":"Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats","volume":"45","author":"Ando","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.07.001_b0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bcp.2016.07.001_b0130","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.2337\/db14-1947","article-title":"Mechanism of altered metformin distribution in nonalcoholic steatohepatitis","volume":"64","author":"Clarke","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2016.07.001_b0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S0007114514003717","article-title":"Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition","volume":"113","author":"Ghoneim","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bcp.2016.07.001_b0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.114.220764","article-title":"Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis","volume":"352","author":"Dzierlenga","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2016.07.001_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp700114j","article-title":"Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity","volume":"5","author":"Cheng","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2016.07.001_b0150","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/dmd.110.037507","article-title":"Alteration of hepatic but not renal transporter expression in diet-induced obese mice","volume":"39","author":"More","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.idc.2007.07.004","article-title":"Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations","volume":"21","author":"Bergman","year":"2007","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.bcp.2016.07.001_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bcp.2016.07.001_b0165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.2014.936378","article-title":"Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis","volume":"10","author":"Canet","year":"2014","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2016.07.001_b0170","first-page":"747","article-title":"Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine","volume":"20","author":"Naesens","year":"1992","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0175","first-page":"362","article-title":"Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats","volume":"25","author":"Shaw","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2016.07.001_b0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tiv.2014.11.015","article-title":"Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing","volume":"30","author":"Crean","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2016.07.001_b0185","first-page":"267","article-title":"Determination of the glomerular filtration rate (GFR): methodological problems, age-dependence, consequences of various surgical interventions, and the influence of different drugs and toxic substances","volume":"48","author":"Fleck","year":"1999","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bcp.2016.07.001_b0190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1113\/jphysiol.1977.sp012061","article-title":"Developmental changes in nephron number, proximal tubular length and superficial nephron glomerular filtration rate of rats","volume":"272","author":"Solomon","year":"1977","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2016.07.001_b0195","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1572-0241.2007.01709.x","article-title":"Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment","volume":"103","author":"Carter-Kent","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bcp.2016.07.001_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1684\/ecn.2012.0313","article-title":"TNF-\u03b1 messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis","volume":"23","author":"Alaaeddine","year":"2012","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcp.2016.07.001_b0205","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2013.08.031","article-title":"Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions","volume":"342","author":"Kochi","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2016.07.001_b0210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2213-8587(15)00128-X","article-title":"Association of age and BMI with kidney function and mortality: a cohort study","volume":"3","author":"Lu","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2016.07.001_b9000","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13104","article-title":"Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues","author":"Liu","year":"2016","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2016.07.001_b0215","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ar.20715","article-title":"Hepatic microcirculation in fatty liver disease","volume":"291","author":"Farrell","year":"2008","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.bcp.2016.07.001_b0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.surg.2009.06.037","article-title":"Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock","volume":"146","author":"Matheson","year":"2009","journal-title":"Surgery"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T15:50:26Z","timestamp":1656777026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216301666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"alternative-id":["S0006295216301666"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.07.001","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}